A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated ...

A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional ...

After a routine C-section at an Auckland hospital, a mother developed severe pain and what seemed like postnatal fatigue. It ...

A recent randomized clinical trial has found that dalbavancin, a long-acting lipoglycopeptide antibiotic, does not provide ...

The results of a randomized clinical trial suggest that patients with serious bloodstream infections caused by Staphylococcus ...

Among 200 patients, the probability of a more desirable day-70 outcome with two doses of intravenous dalbavancin versus 4 to ...

By Dennis Thompson HealthDay ReporterTHURSDAY, Aug. 14, 2025 (HealthDay News) — A new way to battle bloodborne staph ...

Before surgery, patients may be offered an MRSA screening test, the NHS says. This involves taking swabs from the nostrils, ...

Airplane bathrooms aren’t exactly the most pleasant, comfortable, or even hygienic experiences. But their sheer number of ...

Dalbavancin is not superior to standard therapy for adults with complicated Staphylococcus aureus bacteremia, but clinical ...